Related Experiment Video
Updated: Jun 18, 2025
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Soluble ST2: A Novel Biomarker for Diagnosis and Prognosis of Cardiovascular Disease
1Department of Cardiology, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Insights
Soluble ST2 (sST2) shows promise as a reliable biomarker for cardiovascular diseases (CVDs). Unlike traditional markers, sST2 offers accurate risk stratification unaffected by confounding factors, improving patient outcomes.
Area of Science:
- Biomedical science
- Cardiology
- Biomarker research
Background:
- Cardiovascular diseases (CVDs) represent a major global health challenge.
- Accurate diagnosis of acute CVD is critical for patient survival, yet traditional biomarkers face limitations due to confounding factors like age and renal function.
- Soluble ST2 (sST2) emerges as a novel biomarker with significant association with various CVDs.
Purpose of the Study:
- To provide a comprehensive review of the diagnostic and prognostic value of sST2 in CVDs.
- To highlight sST2's potential as a myocardial marker.
- To discuss the advantages of sST2 over traditional biomarkers and its limitations.
Main Methods:
- Literature review of studies investigating sST2 in cardiovascular diseases.
- Analysis of sST2's properties, including its low reference change value and independence from confounding factors.
- Evaluation of sST2's performance in risk stratification and its combination with other biomarkers.
Main Results:
- sST2 is closely associated with different types of CVDs.
- Its low reference change value allows for continuous measurement, unaffected by age, sex, or renal function.
- Combining sST2 with other biomarkers enhances diagnostic accuracy and prognostic value.
Conclusions:
- sST2 demonstrates significant potential as a reliable diagnostic and prognostic biomarker for CVDs.
- Its robustness against confounding factors makes it suitable for continuous monitoring and risk stratification.
- Further research is warranted to address the current limitations of sST2 in clinical practice.
Abstract:
The increasing incidence of cardiovascular disease (CVD) is a significant global health concern, affecting millions of individuals each year. Accurate diagnosis of acute CVD poses a formidable challenge, as misdiagnosis can significantly decrease patient survival rates. Traditional biomarkers have played a vital role in the diagnosis and prognosis of CVDs, but they can be influenced by various factors, such as age, sex, and renal function. Soluble ST2 (sST2) is a novel biomarker that is closely associated with different CVDs. Its low reference change value makes it suitable for continuous measurement, unaffected by age, kidney function, and other confounding factors, facilitating risk stratification of CVDs. Furthermore, the combination of sST2 with other biomarkers can enhance diagnostic accuracy and prognostic value. This review aims to provide a comprehensive overview of sST2, focusing on its diagnostic and prognostic value as a myocardial marker for different types of CVDs and discussing the current limitations of sST2.
More Related Videos
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...